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A new indirect fluorescent-antibody (IFA) assay with antigen produced in vitro in the human promyelocytic
leukemia cell line HL60 was used to identify the first recognized case of human granulocytic ehrlichiosis in
Rhode Island. This IFA assay was used to detect granulocytic ehrlichiae in white-footed mice and in a dog
inhabiting the area surrounding the patient’s residence. Host-seeking Ixodes scapularis ticks found in the same
habitat also were infected. I. scapularis ticks collected from other locations were fed on dogs and New Zealand
White rabbits to assess the competency of these species as hosts of granulocytotropic Ehrlichia. Tick-induced
infections of dogs were confirmed by serologic testing, tissue culture isolation, and PCR amplification, whereas
several rabbits seroconverted but were PCR and culture negative. PCR amplification of the 16S rRNA gene and
DNA sequencing of the PCR products or culture isolation was used to confirm granulocytic Ehrlichia infections
in humans, dogs, white-footed mice, and ticks.
The agent of human granulocytic ehrlichiosis (HGE), a
newly emerged tick-transmitted infection, is closely related to
two veterinary pathogens, Ehrlichia equi and Ehrlichia phago-
cytophila, the agents of equine granulocytic ehrlichiosis (2,
15–17) and caprine ehrlichiosis (10), respectively. Both HGE
and equine granulocytic ehrlichiosis appear to be tick trans-
mitted (1, 3, 4, 15, 22, 26). Patients with HGE often exhibit
relatively nonspecific clinical symptoms, including fever, chills,
severe headache, and myalgia. Hematologic findings often in-
clude anemia, thrombocytopenia, and leukopenia, and moru-
lae may be seen in the cytoplasms of neutrophils (1, 4, 12, 26,
27). HGE recently has emerged in several localities in the
United States, including California, Massachusetts, Minnesota,
New York, and Wisconsin, is occasionally fatal, and poses a
serious threat to public health (1, 3, 4, 11, 12, 26, 27).
Recent reports have shown that dogs may serve as hosts for
granulocytotropic Ehrlichia (GE) that is indistinguishable on
the basis of 16S ribosomal DNA sequences from the agent that
causes HGE (13, 14). Likewise, recent experimental-transmis-
sion studies have shown that rodents are competent host spe-
cies for such GE (25). Evidence implicating Ixodes scapularis
ticks as a vector has been provided by several groups (18, 22,
25). Although those studies indicate the potential of those
species as hosts, broader studies using reliable serologic and
molecular methods will be needed to identify the natural res-
ervoirs and vectors of GE and to determine the extent of
human infection risk.
E. equi-infected horse leukocytes have been successfully
used to detect antibodies against HGE organisms by indirect
fluorescent-antibody assay (IFA) for humans clinically diag-
nosed with HGE (7, 12), but preparation of E. equi antigen is
inconvenient. Not only do horses need to be inoculated with E.
equi but also Ehrlichia-infected leukocytes need to be sepa-
rated from the erythrocytes during the peak of bacteremia (7,
16, 21). We report here on the first use of an IFA with GE
antigen derived from HL60 cell cultures for serologic studies of
GE in different animals. This method also was used to identify
the first reported case of HGE in Rhode Island.
MATERIALS AND METHODS
Isolation of HGE in cell culture. The human promyelocytic leukemia cell line
HL60 (ATCC CCL 240) was used to isolate GE from blood samples. Cells were
cultured in RPMI 1640 supplemented with 10 to 20% heat-inactivated fetal
bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, and 0.1 mM minimal
essential medium nonessential amino acids. Cells were maintained at 378C and
6% CO2 in a humidified chamber. The HGE agent (strain USG3) was originally
isolated in 1994 from a purpose-bred beagle challenged experimentally by adult
I. scapularis ticks collected from both Westchester County, N.Y., and Montgom-
ery County, Pa. Confirmation of the newly isolated Ehrlichia was made by PCR
assay and DNA sequence analysis.
Preparation of antigen. GE antigen was prepared from stock cultures of the
USG3 strain grown in HL60 cells. Cultures grown for 2 to 3 days were harvested
by centrifugation at 2,000 3 g for 10 min. Cell pellets were washed three times
by suspension in 500 ml of phosphate-buffered saline (PBS) (0.01 M, pH 7.38),
recentrifugation at 12,000 3 g for 25 s, and removal of the supernatant. After
being washed, the cell pellet was resuspended in PBS to a final concentration of
5 3 107 cells/ml. Ten microliters of this cell suspension was applied to each of
eight wells on a Teflon-coated glass slide (Cell-Line, Newfield, N.J.). Slides were
air dried, fixed in acetone for 10 min, and stored in airtight containers at 2708C
until use. Uninfected HL60 cell suspensions were prepared by the same proce-
dure to make antigen-free control slides.
Blood and serum collections. Serum samples from patients having a history of
tick bites from adult I. scapularis and of fever, headaches, muscle aches, and
fatigue were obtained from attending physicians in South Kingstown and
Charlestown, R.I. Twelve human serum samples were collected from September
to October 1995. Whole blood and serum were also collected from six purpose-
bred beagles exposed to the bites of numerous (.20 pairs) adult I. scapularis
ticks collected from sites in Connecticut, Indiana, New York, North Carolina,
Pennsylvania, and Rhode Island (5). Blood was collected from these six dogs by
venipuncture prior to, and at 2 and 4 weeks following, tick feeding. In addition,
blood and serum were taken from a dog residing in the area surrounding the
home of a patient with confirmed HGE (23). The dog reportedly was nearly
continually infested with nymphal and adult I. scapularis ticks.
White-footed mice (Peromyscus leucopus) also were livetrapped at the resi-
dence of this HGE patient in coastal Charlestown, R.I., during a 4-week period
between October and November 1995. After their capture, mice were trans-
ported to biosafety level 2/3 facilities at the University of Rhode Island. All mice
were tagged and anesthetized with 2% methoxyflurane (Metofane; Pitman-
Moore Inc., Mundelein, Ill.), and whole-blood samples were obtained by cardiac
puncture and either mixed with EDTA or left untreated. Serum was collected
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from a portion of the sample, and the EDTA-containing blood was frozen and
stored for PCR analysis.
New ZealandWhite rabbits were exposed to the bites of numerous (.45 pairs)
adult I. scapularis ticks collected from sites where HGE had previously been
detected (28). Blood was collected from seven rabbits by venipuncture of the ear
prior to and 4 weeks following tick feeding. Sera were prepared and stored at
2708C.
Immunofluorescence assay. Sera from human patients, dogs, feral white-
footed mice, and tick-challenged rabbits were initially diluted with PBS in two-
fold serial dilutions. Control sera from healthy dogs (n5 6), rabbits (n5 7), mice
(n 5 6), and symptom-free humans (n 5 3) were processed in the same way.
Each diluted serum sample was applied to IFA slides coated with HGE agent
(USG3)-infected HL60 cells and to slides treated with uninfected HL60 cells.
Slides were incubated in a humid chamber for 30 min at 378C. Any unbound
antibody was removed by soaking the slides in PBS for 20 min. Slides were air
dried. Fluorescein isothiocyanate (FITC)-labeled goat anti-human immunoglob-
ulin G (IgG) conjugate (Southern Biotechnology Associates Inc., Birmingham,
Ala.), FITC-labeled anti-dog IgG, FITC-labeled anti-white-footed-mouse IgG
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.), and FITC-labeled
goat anti-rabbit IgG (Sigma Chemical Co., St. Louis, Mo.) were diluted in PBS
(optimum working dilutions were 1:50, 1:20, 1:10, and 1:80, respectively), and 20
ml of each dilution was applied to each well. Slides were incubated again for 30
min and then soaked in PBS for 20 min. Slides were mounted with PBS-glycerol
(1:9) and examined at magnifications of 340 and 3100. Cutoff values for posi-
tives were chosen as the next doubling dilution above the value at which non-
specific autofluorescence was observed in the negative control sera.
DNA purification. Total DNA was purified from 200 ml of EDTA-containing
whole blood by using the QIAamp blood purification kit (Qiagen Inc., Chats-
worth, Calif.). The protocol used was as suggested by the manufacturer. Briefly,
cells were lysed during a 10-min incubation at 708C and then applied to a
QIAamp spin column containing a silica gel-based membrane. Cellular debris
was removed by centrifugation and subsequent washes. Purified DNA was eluted
from the columns in 200 ml of Tris (10 mM, pH 8.0) and stored at 4 or 2208C
until used as a template for PCR amplification.
PCR amplification. PCR amplification was performed with primers designed
to amplify the 16S rRNA genes of two species of GE, E. equi and E. phagocy-
tophila, and the HGE agent. The GenBank/EMBL accession numbers for 16S
rRNA DNA sequences that were used for primer design were M73223 (E. equi),
M73220 (E. phagocytophila), and U02521 (HGE agent). Primer GE3a is the
forward primer and corresponds to bases 36 to 60 of the HGE agent 16S
sequence. Primers EC102 and GE2 are reverse primers and correspond to the
complement of HGE agent 16S nucleotides 734 to 758 and 571 to 594, respec-
tively.
Primary PCR amplification was performed with 10 ml of the purified DNA as
the template. Reagents were from the GeneAmp PCR kit with AmpliTaq DNA
polymerase (Perkin-Elmer), and reactions were performed in a volume of 100 ml
in a Perkin-Elmer 9600 thermal cycler. Each primary PCR amplification mixture
contained 200 mM each deoxynucleoside triphosphate (dATP, dCTP, dGTP, and
dTTP), 2.5 U of Taq polymerase, and 0.5 mM (each) primers GE3a (59 CACA
TGCAAGTCGAACGGATTATTC) and EC102 (59 GCGTGGACTACAAGG
GTATCTAAT). An initial 2-min denaturation at 958C was followed by 40 cycles,
each consisting of a 30-s denaturation at 948C, a 30-s annealing at 558C, and a
1-min extension at 728C. After completion of the 40 cycles, a single 5-min
extension at 728C was done.
The heminested PCR was performed by using 1 ml of the primary PCR
product as the template. Each nested-amplification mixture contained 200 mM
each deoxynucleoside triphosphate (dATP, dCTP, dGTP, and dTTP), 2.5 U of
Taq polymerase, and 0.2 mM (each) primers GE3a and GE2 (59 GGCAGTAT
TAAAAGCAGCTCCAGG) in a total reaction volume of 100 ml. Nested-cycling
conditions were identical to those for the primary reactions, except that 25 cycles
were used. Reaction products were maintained at 4 or 2208C until analyzed by
agarose gel electrophoresis and DNA sequencing.
DNA sequencing. PCR products were purified with Wizard PCR Preps (Pro-
mega Corp.) according to the manufacturer’s instructions. DNA sequencing
reactions were performed with fluorescence-labeled dideoxynucleotides, with
amplification in a Perkin-Elmer 9600 thermal cycler. Sequencing products were
analyzed with an ABI 377 automated DNA sequencer and compared with pre-
viously published sequences by using the Genetics Computer Group (Madison,
Wis.) program package on a SUN workstation (Sun Microsystems, Inc., Moun-
tain View, Calif.).
RESULTS
IFA results for serum samples taken from 12 patients indi-
cated that only 1 patient had been exposed to GE (Table 1).
This patient’s IgG titer was 512 when tested 5 weeks following
acute symptoms and was 1,024 when tested 11 weeks later.
PCR confirmation of HGE was obtained in tests conducted on
the first but not on the follow-up blood sample from this
patient (Fig. 1, lanes 1 and 2). Serum from the dog residing at
the property adjacent to that of this patient also exhibited a
high IFA IgG titer (1:1,024); the blood sample from the dog
was also positive for HGE in the PCR assay (Fig. 1, lane 3).
Both the patient and the dog had experienced clinical symp-
toms consistent with infection by GE, although parasite inclu-
FIG. 1. Agarose gel electrophoresis of PCR products resulting from ampli-
fication of 16S ribosomal DNA of GE. Lanes labeled M represent molecular
standards; sizes (in base pairs) are indicated on the left. Samples include a
sample from a patient from Rhode Island, 5 weeks postinfection (lane 1); a
sample from the same patient, 15 weeks postinfection (lane 2); a sample from a
dog (lane 3); samples from field-collected P. leucopus mice (lanes 4 to 7); and
samples from field-collected I. scapularis ticks (lanes 8 to 11). Lanes labeled 1
and 2 represent positive and negative controls, respectively. The size of the GE
16S ribosomal DNA amplified product is indicated on the right.
TABLE 1. Reciprocal titers of IgG antibody to culture-derived HGE agent in an IFA with sera from various naturally and








PCR or culture confirmation
(no. positive/no. tested)
Human 12 1 ,32 512 1/1
Doga 6 2 ,64 256–512 2/6
Dogb 1 1 ,64 1,024 1/1
White-footed mouse 26 4 ,32 64–256 1/4
New Zealand White rabbit 7 2 ,64 256 0/2
a Purpose-bred beagles challenged with field-collected ticks from various locations.
b Naturally infected dog from Charlestown, R.I.










sions were not observed in thick or thin Wright- or Giemsa-
stained smears. The patient had acute symptoms, including
severe myalgia, fever, and lassitude. The dog exhibited mild
depression but rather normal hematologic findings, except an
elevation of its band neutrophils.
Questing adult I. scapularis ticks were collected from the
yard of the HGE patient and examined for Ehrlichia organisms
by PCR. Two of 15 female and 2 of 15 male ticks were positive
for the organism, indicating that approximately 13% of adult
ticks in this location contained GE (Fig. 1, lanes 8 to 11). The
DNA sequences determined for the 559-bp PCR products am-
plified from the human, dog, rodent, and tick samples were
identical and corresponded to HGE agent sequences previ-
ously described (4). We also tested sera collected from 26
white-footed mice trapped at the residence of the aforemen-
tioned patient. In total, 4 of the 26 samples had positive IFA
IgG titers ranging between 64 and 256 (Table 1). One of these
four mice (titer, 256) was confirmed as being HGE agent
positive by the PCR assay (Fig. 1, lanes 4 to 7). Control PCR
results for Ehrlichia chaffeensis, obtained with DNA purified
from the human, rodent, and tick samples, were all negative
(data not shown).
Additional ticks, collected either from the yard of the patient
or from two other sites located in southern Rhode Island and
one site near Philadelphia, Pa., were used to challenge dogs
and rabbits in the laboratory. Both dogs and rabbits challenged
with field-collected ticks appeared to become infected as de-
termined by our IFA procedure. Two of the six dogs had
elevated anti-HGE IgG titers (512 and 256) by the fifth week
following tick bite challenge (Table 1). In both cases, HGE
organisms were isolated from blood samples and inoculated
into fresh HL60 cell cultures. Preinfection IFA and culture
samples from all dogs were negative, as were the postinfection
samples taken from the other four dogs (IFA IgG titers, ,64).
Of the seven rabbit sera tested, two exhibited positive IgG
titers (256); one of these was from a rabbit challenged with
ticks collected from the yard of the HGE patient. The other
was from a rabbit challenged with ticks from a cohort that also
successfully infected one of the two culture-positive dogs.
However, HGE organisms could not be cultivated from any of
the rabbit blood samples, nor was any of these samples positive
by PCR assay.
Species-specific control sera generally failed to react with
culture-derived HGE in the IFA at or above a 1:16 dilution for
human and mouse samples and a 1:32 dilution for dogs and
rabbits. An exception occurred with one of the experimentally
challenged dogs, for which both the pre- and post-tick chal-
lenge IgG titers were 128. All positive sera resulted in brightly
staining intracellular morulae as well as in extracellular ehrli-
chial elementary bodies, while only slight background fluores-
cence was seen in noninfected HL60 cells irrespective of
whether the sample was positive or negative (Fig. 2).
DISCUSSION
The human promyelocytic leukemia cell line HL60 has re-
cently been used to isolate GE from human and canine blood
(6, 12). This cell line appears to be highly susceptible to infec-
tion; on the basis of 16S ribosomal DNA sequences, all GE
organisms cultivated in HL60 cells derived from various
sources have exhibited similarities to the veterinary pathogens
E. equi and E. phagocytophila. Serologic cross-reactivity be-
tween the agent cultivated in HL60 cells and E. equi derived
from horse blood has also been noted, and it is possible that
these agents represent a single species.
An IFA with HL60 cells infected with the USG3 strain of
GE as the antigen was used to detect the first case of HGE in
Rhode Island. The infection was confirmed by a positive PCR
assay performed 5 weeks after the initial onset of acute-phase
symptoms. The patient had been treated with amoxicillin for
suspected Lyme disease during this interval but remained
somewhat symptomatic throughout the period. The only pre-
vious report of a protracted HGE infection was for a patient
from the upper midwestern United States who was PCR pos-
itive 21 days after the onset of symptoms (8), although similar
cases of prolonged fever have been described for E. chaffeensis
infections of humans (9, 24). These data suggest that both the
monocytic and the granulocytic forms of human ehrlichiosis
have the potential to be prolonged and to include low-grade
fever.
Recognition of the first HGE case in Rhode Island caused us
to extend this study to investigate potential natural host reser-
voirs and vectors of the HGE agent in the area surrounding the
home of the patient who presented the index case. Within this
relatively rural area, a neighbor, who was also symptomatic,
remained IFA negative for HGE but was positive for antibod-
ies to Borrelia burgdorferi, the agent of Lyme disease. From the
same area, the one dog tested was both IFA and PCR positive
for HGE, and 13% of adult deer ticks were also PCR positive
for HGE. Additionally, 15% of white-footed mice were IFA
positive, supporting experimental-transmission studies that
FIG. 2. Immunofluorescence of GE-infected human serum on either nonin-
fected HL60 cells (A) or HL60 cells infected with the USG3 strain of HGE (B).
Serum was diluted to 1:32. Bars, 5.0 mm.










have described P. leucopus as a competent host for GE (25).
Together, these data suggest that GE is relatively common at
this location and presents a significant potential for causing
human and veterinary infections. Additional studies will be
required to determine if GE is focally restricted to this site or
whether this location more broadly represents the situation
found throughout regions where I. scapularis is endemic in
southern Rhode Island (20) and elsewhere. Magnarelli et al.
(18) reported a similar proportion of I. scapularis ticks positive
for GE in two Connecticut towns as determined by reactivity to
E. equi antibody in an IFA. However, in the same study, other
tick samples tested by PCR indicated that GE infection rates
for I. scapularis populations in Connecticut ranged from 10 to
91%. The reasons for such discrepancies are not yet under-
stood, but primer specificity must always be considered when
discussing PCR-based results. In the present study, a novel
heminested PCR assay was employed. The specificity of this
assay for identifying GE DNA from the samples tested in this
study was confirmed by DNA sequencing of all PCR products.
The sequences determined for the PCR products from mice,
ticks, and a human were identical to the 16S rRNA DNA
sequence of the HGE agent previously described (4).
When we challenged laboratory-bred dogs with ticks col-
lected from Rhode Island and other sites, two of six dogs
became infected with GE, confirming the competency of ca-
nines as hosts and I. scapularis as a vector of GE. An analogous
experiment with New Zealand White rabbits resulted in sero-
conversions in two of seven animals. However, DNA samples
from seropositive rabbits were consistently PCR negative, sug-
gesting that if an infection was established, it either was very
transient or involved a site with a noncirculating cell population.
To date, serologic diagnosis of HGE has depended on visu-
alizing parasites in granulocytes purified from horses acutely
infected with E. equi (1). Consequently, serologic testing was
not widely practiced because it required obtaining buffy coat
smears or purified granulocytes from infected animals. Culti-
vation of the HGE agent in HL60 cells makes it possible to
obtain large quantities of specific antigen. We have shown that
the GE antigen produced in cell culture was reactive with sera
from an infected human, dogs, and mice, all from a site where
a GE infection occurred, as confirmed by either PCR or cul-
ture. The availability of the USG3 strain as an antigen should
facilitate diagnostic and epidemiologic studies, and the strain
can be used for the development of more sensitive diagnostic
assays. Additional studies will be necessary to determine the
relationship of the USG3 strain to other isolates or clinical
samples of HGE and E. equi, although preliminary molecular
and antigenic studies have found no significant differences
among any of the North American GE samples tested to date
(2, 7, 13, 17, 19).
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